Breast cancer death rates in the UK have reached a record low, plummeting by a sixth over the past decade. This 'fantastic' reduction, a 16% decrease in the last ten years alone and a 41% fall since the 1970s, is attributed by experts to 'huge strides' in earlier diagnoses and more effective treatments. According to Cancer Research UK, there are now 30 breast cancer deaths per 100,000 people, a significant drop from 52 per 100,000 in 1971.

Despite these improvements, breast cancer continues to be the second biggest cause of cancer death in women in the UK, only surpassed by lung cancer. Annually, the disease accounts for 56,000 new cases and 11,500 deaths. The charity highlights that the decline in mortality is largely due to more accurate and less invasive screening techniques, as well as the development of breakthrough drugs like tamoxifen, anastrozole, and Herceptin. These advancements, supported by Cancer Research UK, can put the disease into remission and prevent recurrence.

Catching breast cancer early, before it has spread to other parts of the body, is crucial for increasing survival chances and making treatment easier and more cost-effective. For instance, if detected at Stage One, where the cancer is localized, 98 out of 100 patients will be alive five years later. In stark contrast, if detected at Stage Four, after it has spread throughout the body, only 27 in 100 will survive for the same period.

However, further reductions in death rates are possible. Latest figures show that approximately one in three eligible women in England, nearly 2 million individuals, are not up-to-date with their breast cancer screening, potentially leaving many tumours undetected. Cancer Research UK emphasizes that increased screening uptake and the adoption of healthier lifestyles, including reduced alcohol intake, quitting smoking, and maintaining a healthy body weight, could significantly lower death rates.

Sophie Brooks, health information manager at Cancer Research UK, reiterated the importance of these efforts, stating that early diagnosis and treatment are essential. She also encouraged individuals to consult their GP if they notice any unusual changes to their breast or chest, as early detection greatly improves treatment success. NHS breast screening is automatically offered to women aged 50 up to their 71st birthday, with invitations sent every three years after their first between ages 50 and 53.